The healthcare analytics software startup doubled its funding with a $10m round led by Intel Capital that included existing backer BlueCross BlueShield Venture Partners.
US-based predictive analytics technology developer Lumiata has raised $10m in a round led by Intel Capital, the chipmaker’s corporate venturing unit, doubling its overall funding in the process.
Blue Cross Blue Shield Venture Partners, the corporate venturing fund sponsored by health insurance provider BlueCross and BlueShield Association, also took part in the round, as did venture capital firms Sandbox Industries and Khosla Ventures.
Founded in 2013, Lumiata is developing an artificial intelligence-equipped data analytics platform for healthcare provision. The Lumiata…
